William A. Bulman, M.D.

Associate Professor of Medicine at Columbia University Medical Center
Director of Bronchoscopy
Medical Director of Pulmonary Associates
Associate Program Director of Pulmonary and Critical Care Fellowship


Dr. William A. Bulman is an Associate Professor of Medicine at Columbia University Medical Center in the Division of Pulmonary, Allergy and Critical Care, and serves as the Director of Bronchoscopy and the Director of Interventional Bronchoscopy at New York Presbyterian Hospital – Columbia. He is a graduate of the University of Pennsylvania School of Medicine, and he completed internships in both surgery and medicine before residency training in Internal Medicine. He served as a Chief Resident in Medicine and later completed fellowship training in Pulmonary and Critical Care Medicine at Columbia.

Dr. Bulman is the course co-director for the Pulmonary Medicine Section of the first year curriculum at Columbia University Vagelos College of Physicians and Surgeons. He is the co-director of the Clinical Research Track in the medical school’s Scholarly Projects Program. He is the medical director of the High Risk Lung Nodule Assessment Center and the medical director of Columbia Pulmonary Associates, a private practice group in Price Center for Comprehensive Chest Care. His clinical interests include Interventional Bronchoscopy and Advanced Diagnostic Bronchoscopy, chronic obstructive pulmonary disease, and the pulmonary complications of lung cancer. He has been a research investigator in multiple clinical trials involving bronchoscopic treatments for emphysema and studies the use of optical coherence tomography in bronchoscopic the imaging of the lung.

Education and Training

B.S. Biology Summa Cum Laude University of Scranton, Scranton PA 1989
Medical School:
University of Pennsylvania School of Medicine, Philadelphia, PA 1994
Internal Medicine, Columbia Presbyterian Medical Center, New York, NY, 1995-1996
General Surgery, New York University Medical Center, New York, NY 1994-1995
Internal Medicine, Columbia Presbyterian Medical Center, New York, NY, 1996-1999
Chief Residency:
Internal Medicine, Columbia Presbyterian Medical Center, New York, NY, 1998-1999
Pulmonary and Critical Care, Columbia Presbyterian Medical Center, New York, NY, 2005-2008

Selected Honors and Awards

  • 1993 Alpha Omega Alpha
  • 1989 Summa Cum Laude and Salutatorian, University of Scranton
  • 1989 NCAA Scholar Athlete, Middle Atlantic Conference

Professional Memberships

  • American Thoracic Society (ATS)
  • American Association for Bronchology and Interventional Pulmonology (AABIP)


For appointments: 

Columbia Pulmonary Associates
Herbert Irving Pavilion
161 Fort Washington Avenue, 310
New York, NY 10032

P: 212-305-1544
F: 212-342-1882


  • Pulmonary Disease Medicine
  • Critical Care Medicine
  • Interventional Bronchoscopy

Clinical Expertise

  • Interventional bronchoscopy
  • Minimally invasive diagnosis and staging of lung cancer
  • COPD
  • Acute respiratory Failure

Clinical Centers

Board Certifications

  • Internal Medicine Diplomate, 2008
  • Pulmonary Disease Diplomate, 2007
  • Critical Care Medicine Diplomate, 2008


Research Interests

  • Bronchoscopic treatments for emphysema
  • Molecular diagnosis of lung cancer using minimally invasive sampling techniques

Selected Publications

  1. Bulman WA, Iannotti JP, Glowacki K, Bleuit J, Clark CC. Serum fractions and related agonists with calcium-mobilizing activity in the bovine growth plate chondrocyte. Journal of Orthopedic Research. 1995 Mar; I3(2):220-229.
  2. Ecker ML, Oonnans JP, Schwartz OM, Drummond OS, Bulman \VA. Efficacy of spinal cord monitoring in scoliosis surgery in patients with cerebral palsy. Journal of Spinal Disorders. 1996 Apr;9(2): 159-164.
  3. Bulman WA, Oonnans JP, Ecker ML, Drummond OS. Posterior spinal fusion for scoliosis in patients with cerebral palsy: a comparison of Luque rod and Unit Rod instrumentation. Journal of Pediatric Orthopedics. 1996 May-lull; 16 (3):314-323.
  4. Bulman WA, et al. Suspicion of Lung Cancer with Nodal Metastases in an Immunocompromised Patient. ATS Clinical Cases (published online at www.thoracic.org, October 2007)
  5. Bulman WA, et al. Severe Pulmonary Hypertension due to Chronic Echinococcal Pulmonary Emboli Treatcd with Targeted Pulmonary Vascular Therapy and Hcpatic Resection. CHEST 2007 Oct; 132(4): 1356-1358.
  6. Bulman WA, et al. Durability of Benefit of Lung Volume Reduction Surgery: 3 and 4 year followMup after NE1T. Poster presentation, American Thoracic Society International Conference, May 2009.
  7. Weiser JA, Scully BE, Bulman WA, Husai, S, Grossman ME. Periumbilical parasitic thumbprint purpura: Strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transpl [nfect Dis. 2010 May 26.
  8. Bulman WA Lung Volume Reduction for the Treatment of Severe Emphysema: Past, Present and Future. Symposium Session, American College of Chest Physicians International Conference, October 2010. (Session Chair)
  9. Ginsburg ME, Thomashow BM, Yip CK, DiMango Alvt, Maxfield RA, Bartels r-.rn, Jellen P, Bulman WA, Lederer 0, Brogan FL, Gorenstein LA, SoneU JR. Lung volume reduction surgery using the NETT selection criteria. Ann Thorne Surg. 2011 May; 91 (5): 1556-60.
  10. Bulman W, Saqi A, Powell CA. Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy. Am J Respir Crit Care Med. 2012 Mar; 185:606-611.
  11. Jurrado J, Saqi A, Maxfield RA, Newmark A, Lavelle M, Bacchetta M, Gorenstein L, Dovidio, Mark E. Ginsburg ME, Sonett JR and Bulman WA. The Efficacy of EBUS-guided transbronchial needle aspiration for molecular testing in lung adenocarcinoma. Ann Thorac Surg. 2013 Oct; 96(4):1196-1202.
  12. Heymann JJ, Bulman WA, Maxfield RA, Powell CA, Halmos B, Sonett J, Beaubier N, Crapanzano JP, Mansukhani MM, Saqi A. Molecular testing guidelines for lung adenocarcinoma: Utility of cell blocks and concordance between fine‑needle aspiration cytology and histology samples. CytoJournal 2014 Jan: 11(1):1-7.
  13. Pareja F, Crapanzano JP, Mansukhani MM, Bulman WA, Saqi A. Cytomorphological features of ALK-positive lung adenocarcinomas: Psammoma bodies and signet ring cells. Cancer Cytopathol. 2014 Dec 29.
  14. Ginsburg ME, Thomashow BM, Bulman WA, Jellen P, Whippo BA, Chiuzan C, Lee S, Bai D, Sonett JR. The Safety, Efficacy, and Durability of Lung Volume Reduction Surgery: A 10-Year Experience. J of Thoracic and Cardiothoracic Surgery. J Thorac Cardiovasc Surg. 2016 Mar;151(3):717-24.
  15. DiBardino DM, Saqi A, Elvin JA, Greenbowe J, Suh JH, Miller VA, Ali SM, Stoopler M, Bulman WA. Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma. Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30133-4.

View Dr. Bulman's full list of publications from PubMed